MRKR logo

Marker Therapeutics (MRKR) Cash From Investing

Annual CFI

$18.66 M
+$23.61 M+477.43%

December 31, 2023

Summary

Performance

1-Year Change

+477.43%

3-Year Change

+301.71%

5-Year Change

+12736.49%

15-Year Change

+100%

MRKR Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.48%
MRKR annual cash flow from investing activities is higher than 81.48% of companies in Healthcare sector

High & Low

All-time High

$18.66 M
MRKR annual cash flow from investing activities is currently at an all-time high

3-Year Low

-$4.95 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
MRKR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 25, 2025
MRKR next annual earnings announcement is scheduled for Mar 25, 2025

OtherMRKRcash flowmetrics:

Annual CFF

$1.11 M
MRKR annual cash flow from financing activities is $1.11 million

Annual CFO

-$16.44 M
MRKR annual cash flow from operations is -$16.44 million

Annual FCF

-$16.44 M
MRKR annual free cash flow is -$16.44 million

Annual CAPEX

-
MRKR annual capital expenditures value is unknown

Quarterly CFI

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+100%

MRKR Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.01%
MRKR quarterly cash flow from investing activities is higher than 68.01% of companies in Healthcare sector

High & Low

All-time High

$18.78 M
MRKR quarterly cash flow from investing activities is currently -100.00% below its historical high of $18.78 million

3-Year Low

-$2.45 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MRKR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
MRKR next earnings announcement is scheduled for Mar 25, 2025

OtherMRKRcash flowmetrics:

Quarterly CFF

$1700.00
MRKR quarterly cash flow from financing activities is $1700.00

Quarterly CFO

$1.20 M
MRKR quarterly cash flow from operations is $1.20 million

Quarterly FCF

$1.20 M
MRKR quarterly free cash flow is $1.20 million

Quarterly CAPEX

-
MRKR quarterly capital expenditures value is unknown

TTM CFI

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+100%

MRKR TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

67.26%
MRKR TTM cash flow from investing activities is higher than 67.26% of companies in Healthcare sector

High & Low

All-time High

$18.78 M
MRKR TTM cash flow from investing activities is currently -100.00% below its historical high of $18.78 million

3-Year Low

-$6.05 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
MRKR previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 25, 2025
MRKR next earnings announcement is scheduled for Mar 25, 2025

OtherMRKRcash flowmetrics:

TTM CFF

$100.50 K
MRKR TTM cash flow from financing activities is $100.50 thousand

TTM CFO

-$8.57 M
MRKR TTM cash flow from operations is -$8.57 million

TTM FCF

-$8.57 M
MRKR TTM free cash flow is -$8.57 million

TTM CAPEX

-
MRKR TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

MRKR Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+477.4%0.0%0.0%
3 y3 years+301.7%0.0%0.0%
5 y5 years+10000.0%+100.0%+100.0%

MRKR Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+477.4%-100.0%+100.0%-100.0%+100.0%
5 y5-yearat high+301.7%-100.0%+100.0%-100.0%+100.0%
alltimeall timeat high+301.7%-100.0%+100.0%-100.0%+100.0%

Marker Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2024
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2024
-
$0.00(0.0%)
$18.78 M(+0.6%)
Dec 2023
$18.66 M(-477.4%)
$0.00(0.0%)
$18.66 M(+0.7%)
Sep 2023
-
$0.00(-100.0%)
$18.54 M(+0.5%)
Jun 2023
-
$18.78 M(<-9900.0%)
$18.44 M(-807.6%)
Mar 2023
-
-$112.60 K(-11.5%)
-$2.61 M(-47.3%)
Dec 2022
-$4.95 M(+57.9%)
-$127.30 K(+28.1%)
-$4.95 M(-4.3%)
Sep 2022
-
-$99.40 K(-95.6%)
-$5.17 M(-14.6%)
Jun 2022
-
-$2.27 M(-7.6%)
-$6.05 M(+44.6%)
Mar 2022
-
-$2.45 M(+601.0%)
-$4.18 M(+33.6%)
Dec 2021
-$3.13 M(-66.2%)
-$349.80 K(-64.3%)
-$3.13 M(-54.5%)
Sep 2021
-
-$980.30 K(+145.2%)
-$6.88 M(-3.4%)
Jun 2021
-
-$399.80 K(-71.5%)
-$7.13 M(-32.5%)
Mar 2021
-
-$1.40 M(-65.8%)
-$10.55 M(+14.1%)
Dec 2020
-$9.25 M(+2367.4%)
-$4.10 M(+234.9%)
-$9.25 M(+79.1%)
Sep 2020
-
-$1.22 M(-68.0%)
-$5.17 M(+29.2%)
Jun 2020
-
-$3.83 M(+3736.2%)
-$4.00 M(+1488.4%)
Mar 2020
-
-$99.80 K(+673.6%)
-$251.70 K(-32.9%)
Dec 2019
-$375.00 K(+153.9%)
-$12.90 K(-77.2%)
-$375.00 K(-26.4%)
Sep 2019
-
-$56.70 K(-31.1%)
-$509.80 K(+12.5%)
Jun 2019
-
-$82.30 K(-63.1%)
-$453.10 K(+22.2%)
Mar 2019
-
-$223.10 K(+51.0%)
-$370.80 K(+151.0%)
Dec 2018
-$147.70 K(<-9900.0%)
-$147.70 K(<-9900.0%)
-$147.70 K(<-9900.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2017
$0.00(0.0%)
-
-
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2010
$0.00
$0.00(0.0%)
$0.00(0.0%)
Sep 2010
-
$0.00(0.0%)
$0.00(0.0%)
DateAnnualQuarterlyTTM
Jun 2010
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2009
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2008
-
$0.00(0.0%)
-$1300.00(-48.0%)
Mar 2008
-
$0.00(0.0%)
-$2500.00(-88.8%)
Dec 2007
-$22.40 K(<-9900.0%)
$0.00(-100.0%)
-$22.40 K(0.0%)
Sep 2007
-
-$1300.00(+8.3%)
-$22.40 K(+6.2%)
Jun 2007
-
-$1200.00(-94.0%)
-$21.10 K(+6.0%)
Mar 2007
-
-$19.90 K(<-9900.0%)
-$19.90 K(<-9900.0%)
Dec 2006
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2006
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2005
-$2000.00(<-9900.0%)
$0.00(0.0%)
-$2000.00(0.0%)
Sep 2005
-
$0.00(0.0%)
-$2000.00(0.0%)
Jun 2005
-
$0.00(-100.0%)
-$2000.00(0.0%)
Mar 2005
-
-$2000.00(<-9900.0%)
-$2000.00(<-9900.0%)
Dec 2004
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2004
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2004
-
$0.00(0.0%)
-$1400.00(-17.6%)
Mar 2004
-
$0.00(0.0%)
-$1700.00(-22.7%)
Dec 2003
-$2300.00(-100.6%)
$0.00(-100.0%)
-$2200.00(-72.5%)
Sep 2003
-
-$1400.00(+366.7%)
-$8000.00(-101.2%)
Jun 2003
-
-$300.00(-40.0%)
$666.80 K(+59.9%)
Mar 2003
-
-$500.00(-91.4%)
$417.10 K(-0.1%)
Dec 2002
$417.60 K(>+9900.0%)
-$5800.00(-100.9%)
$417.60 K(-15.1%)
Sep 2002
-
$673.40 K(-369.4%)
$492.10 K(-296.8%)
Jun 2002
-
-$250.00 K(<-9900.0%)
-$250.00 K(<-9900.0%)
Mar 2002
-
$0.00(-100.0%)
$0.00(0.0%)
Dec 2001
$0.00(-100.0%)
$68.70 K(-200.0%)
$0.00(-100.0%)
Sep 2001
-
-$68.70 K(<-9900.0%)
-$68.40 K(<-9900.0%)
Jun 2001
-
$0.00(0.0%)
$300.00(-130.0%)
Mar 2001
-
$0.00(-100.0%)
-$1000.00(-65.5%)
Dec 2000
-$2900.00(-92.1%)
$300.00(>+9900.0%)
-$2900.00(-9.4%)
Sep 2000
-
$0.00(-100.0%)
-$3200.00(0.0%)
Jun 2000
-
-$1300.00(-31.6%)
-$3200.00(+68.4%)
Mar 2000
-
-$1900.00
-$1900.00
Dec 1999
-$36.80 K
-
-

FAQ

  • What is Marker Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Marker Therapeutics?
  • What is Marker Therapeutics annual CFI year-on-year change?
  • What is Marker Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Marker Therapeutics?
  • What is Marker Therapeutics quarterly CFI year-on-year change?
  • What is Marker Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Marker Therapeutics?
  • What is Marker Therapeutics TTM CFI year-on-year change?

What is Marker Therapeutics annual cash flow from investing activities?

The current annual CFI of MRKR is $18.66 M

What is the all time high annual CFI for Marker Therapeutics?

Marker Therapeutics all-time high annual cash flow from investing activities is $18.66 M

What is Marker Therapeutics annual CFI year-on-year change?

Over the past year, MRKR annual cash flow from investing activities has changed by +$23.61 M (+477.43%)

What is Marker Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of MRKR is $0.00

What is the all time high quarterly CFI for Marker Therapeutics?

Marker Therapeutics all-time high quarterly cash flow from investing activities is $18.78 M

What is Marker Therapeutics quarterly CFI year-on-year change?

Over the past year, MRKR quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Marker Therapeutics TTM cash flow from investing activities?

The current TTM CFI of MRKR is $0.00

What is the all time high TTM CFI for Marker Therapeutics?

Marker Therapeutics all-time high TTM cash flow from investing activities is $18.78 M

What is Marker Therapeutics TTM CFI year-on-year change?

Over the past year, MRKR TTM cash flow from investing activities has changed by $0.00 (0.00%)